A Breakthrough Treatment for Ulcerative Colitis


10/17/2016  IBD NEWS DAILY: Asana Reports Positive Preclinical Data of Treatment for Ulcerative Colitis

Asana Medical has announced positive data from a preclinical study using an innovative liquid treatment called Extracellular Matrix Hydrogel (ECMH)

10/4/2016  Asana Medical Inc.’s Preclinical Study Indicates Promising Solution to Treat Ulcerative Colitis

Company’s Patented Drug-Free, Non-Surgical Therapy Promotes Tissue Regeneration MIAMI LAKES, FL – October 4th, 2016 – Asana Medical, Inc., (“Asana,” […]

6/1/2016  Asana Medical, Inc. CEO Dr. Christine V. Sapan to Present at 2016 BIO International Convention June 8th

Sapan to Provide Data Findings and Analysis from Company’s Recent Pivotal Preclinical Study MIAMI LAKES, FL – June 1, 2016 […]

More News →

Asana Medical Inc.

Asana Medical Inc. is focused on providing physicians with the first-in-class non-pharmacological, non-surgical treatment option for patients suffering from gastrointestinal (GI) diseases, including Ulcerative Colitis, Crohn’s Disease, and Rectal Mucositis. Asana’s device, derived from Extracellular Matrix, will set into motion a paradigm shift in the treatment of Inflammatory Bowel Disease (IBD) and other diseases from symptom-based, anti-inflammatory therapies to providing a protective coating to promote tissue healing.

We are a GI-oriented company of highly motivated innovators, doctors, scientists, engineers, entrepreneurs, and professionals that identified an opportunity to apply existing Tissue Engineering Technology in a novel application. This will spark a change in the treatment of IBD and other GI diseases.

Facebook Twitter LinkedIn
Asana Medical Inc.
6135 NW 167 Street, Suite E15
Miami Lakes, FL 33015
tel: (844) 432-7262